SALT LAKE CITY- Surgeons at University of Utah Hospital have performed the hospital’s first implant of a new generation left ventricular assist device (LVAD) using the HeartWare HVAD. The tiny, ...
CINCINNATI (WKRC) - Breakthrough technology is transforming the lives of local heart failure patients, offering new hope and improved quality of life. The TriHealth Heart and Vascular Institute is at ...
FRAMINGHAM, MA — The US Food and Drug Administration issued a formal warning to the makers of a recently approved ventricular assist device (VAD) system (HeartWare, Framingham, MA) for failing to take ...
HeartWare International Inc. files a pre-market approval application with the Food & Drug Administration for a ventricular assist device designed as a bridge-to-transplant system. HeartWare ...
As one of two major players in the left ventricular assist device (LVAD) market, HeartWare has been seen as an acquisition target in the past. In fact, LVAD pioneer and HeartWare competitor Thoratec ...
HeartWare International (HTWR), a leading manufacturer of heart devices, recently submitted a Pre-Market Approval (“PMA”) application to the U.S. Food and Drug Administration (“FDA”), for its ...
After issuing near-monthly safety warnings related to its discontinued HeartWare Ventricular Assist Device (HVAD) last year, Medtronic is already continuing the trend in 2023. The heart pump’s first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results